Abbott wins FDA approval for TactiFlex Duo ablation catheter
Abbott announced it received U.S. FDA approval for the TactiFlex Duo Ablation Catheter, Sensor Enabled, to treat challenging atrial fibrillation (AFib) cases.
Story updates
12:03:46 PM UTC
SquawkNews
ABBOTT RECEIVES FDA APPROVAL FOR ITS TACTIFLEX™ DUO ABLATION CATHETER TO TREAT PEOPLE WITH ABNORMAL HEART RHYTHMS || TO BEGIN BROADER COMMERCIAL ADOPTION OF TACTIFLEX DUO IN US IN COMING WEEKS
S. Food and Drug Administration approval for the TactiFlex Duo Ablation Catheter, Sensor Enabled, to treat patients with challenging cases of atrial fibrillation (AFib). The company said the announcement was made on Sept. 8, 2026.